BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23201239)

  • 41. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
    Satterthwaite R; Ozgu I; Shidban H; Aswad S; Sunga V; Zapanta R; Asai P; Bogaard T; Khetan U; Mendez RG; Mendez R
    Transplantation; 1997 Aug; 64(3):432-5. PubMed ID: 9275109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.
    Li Z; Hu Z; Xiang J; Zhou J; Yan S; Wu J; Zhou L; Zheng S
    Liver Transpl; 2014 Jan; 20(1):35-45. PubMed ID: 24142889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.
    Nugroho A; Lee KW; Kim H; Yi NJ; Suh KS
    Transplant Proc; 2019 Apr; 51(3):842-844. PubMed ID: 30979473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation.
    Yaprak O; Dayangac M; Balci D; Demirbas T; Yuzer Y; Tokat Y
    Hepatogastroenterology; 2010; 57(102-103):1268-71. PubMed ID: 21410070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody-Positive Liver Grafts.
    Song Z; Dong C; Meng X; Sun C; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Chen J; Duan K; Bi B; Gao W
    Liver Transpl; 2021 Jan; 27(1):96-105. PubMed ID: 32511854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
    Loggi E; Conti F; Cucchetti A; Ercolani G; Pinna AD; Andreone P
    World J Gastroenterol; 2016 Sep; 22(35):8010-6. PubMed ID: 27672295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
    J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utilization of hepatitis B core antibody-positive donor liver grafts.
    MacConmara MP; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Chapman WC; Doyle MB
    HPB (Oxford); 2012 Jan; 14(1):42-8. PubMed ID: 22151450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.
    Uemoto S; Sugiyama K; Marusawa H; Inomata Y; Asonuma K; Egawa H; Kiuchi T; Miyake Y; Tanaka K; Chiba T
    Transplantation; 1998 Feb; 65(4):494-9. PubMed ID: 9500622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
    Akalin E; Ames S; Sehgal V; Murphy B; Bromberg JS
    Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience.
    Lee YJ; Oh SH; Kim KM; Song SM; Namgoong JM; Kim DY; Lee SG
    Pediatr Transplant; 2015 May; 19(3):267-72. PubMed ID: 25648049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy.
    Dong C; Song Z; Chen J; Ma N; Meng X; Sun C; Duan K; Bi B; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Gao W
    J Gastroenterol Hepatol; 2020 May; 35(5):827-832. PubMed ID: 31609494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B core antibody-positive grafts: recipient's risk.
    de Villa VH; Chen YS; Chen CL
    Transplantation; 2003 Feb; 75(3 Suppl):S49-53. PubMed ID: 12589141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    Lin CC; Yong CC; Chen CL
    World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HBsAg seroconversion in de novo hepatitis B virus-infected paediatric liver transplant recipients with anti-viral therapy.
    Dong C; Song Z; Sun C; Wang K; Chen J; Zhang W; Wu D; Zheng W; Yang Y; Qin H; Han C; Zhang F; Wang Z; Xu M; Zhang G; Xie E; Jiao J; Cao S; Gao W; Shen Z
    J Viral Hepat; 2022 Dec; 29(12):1099-1106. PubMed ID: 36094676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.